Business Description
Active Biotech AB
ISIN : SE0001137985
Compare
Compare
Traded in other countries / regions
BTPC.GermanyACTI.Sweden0GQU.UKATVBF.USA IPO Date
2000-02-28Description
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.58 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -5.5 | |||||
| 3-Year EPS without NRI Growth Rate | -2.8 | |||||
| 3-Year FCF Growth Rate | 0.1 | |||||
| 3-Year Book Growth Rate | -24.2 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.71 | |||||
| 9-Day RSI | 67.44 | |||||
| 14-Day RSI | 58.94 | |||||
| 6-1 Month Momentum % | -21.23 | |||||
| 12-1 Month Momentum % | -23.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.66 | |||||
| Quick Ratio | 2.66 | |||||
| Cash Ratio | 2.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -175.19 | |||||
| ROA % | -117.15 | |||||
| ROIC % | -326.7 | |||||
| ROC (Joel Greenblatt) % | -1071.43 | |||||
| ROCE % | -158.12 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 9.2 | |||||
| Price-to-Tangible-Book | 8.89 | |||||
| EV-to-EBIT | -3.23 | |||||
| EV-to-EBITDA | -3.23 | |||||
| EV-to-FCF | -3.43 | |||||
| Price-to-Net-Current-Asset-Value | 13.33 | |||||
| Price-to-Net-Cash | 16 | |||||
| Earnings Yield (Greenblatt) % | -30.96 |
Balance Sheet Breakdown
Cashflow Statement Breakdown
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Active Biotech AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.227 | ||
| Beta | 3.16 | ||
| Volatility % | 36.43 | ||
| 14-Day RSI | 58.94 | ||
| 14-Day ATR (kr) | 0.078513 | ||
| 20-Day SMA (kr) | 0.6981 | ||
| 12-1 Month Momentum % | -23.63 | ||
| 52-Week Range (kr) | 0.543 - 1.459199 | ||
| Shares Outstanding (Mil) | 265.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Active Biotech AB Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Active Biotech AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Active Biotech AB Frequently Asked Questions
What is Active Biotech AB(OSTO:ACTI)'s stock price today?
The current price of OSTO:ACTI is kr0.80. The 52 week high of OSTO:ACTI is kr1.46 and 52 week low is kr0.54.
When is next earnings date of Active Biotech AB(OSTO:ACTI)?
The next earnings date of Active Biotech AB(OSTO:ACTI) is 2023-08-24.
Does Active Biotech AB(OSTO:ACTI) pay dividends? If so, how much?
Active Biotech AB(OSTO:ACTI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
